➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Merck
Baxter
Mallinckrodt
Harvard Business School

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Litigation Details for Almirall LLC v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Almirall LLC v. Taro Pharmaceutical Industries Ltd.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Almirall LLC v. Taro Pharmaceutical Industries Ltd. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 113 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,517,219 B2 . (Blumenfeld, Jack…2017 11 March 2019 1:17-cv-00663 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 137 would induce infringement of U.S. Patent No. 9,517,219 (“the ’219 patent”) under the doctrine of equivalents…asserted claims are invalid. The ’219 patent is a method patent. The matter is set for trial on February…since the language of the asserted patent claims, and not the patent holder’s commercial product, to define… that during the prosecution of the ’219 patent, the patent examiner defined a POSA as having a level… a POSA for the ’219 patent. Taro proposes: A POSA for the ’219 patent would have had at least External link to document
0000-00-00 39 infringement of United States Patent No. 9,517,219 ("the '219 patent"), which is entitled …;Allergan") brought this civil action for patent infringement under the Hatch-Waxman Act on June…for Use Thereof. (D.I. 1 at if 18) The '219 patent encompasses the approved use of Allergan's …prosecution of the application leading to the '219 patent, which allegedly limited the claimed polymeric…multi-component PVB and the claimed PVB in the '219 patent is the proper subject of fact and expert discovery External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,517,219 B2. (nmg) (Entered:…2017 11 March 2019 1:17-cv-00663 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Colorcon
Merck
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.